(Q41946351)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Intestinal Behçet's disease with pyoderma gangrenosum successfully treated with the combination therapy of adalimumab and glucocorticoids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

0 references

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Yusuke Kashiwado

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Ayumi Uchino

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Shuji Nagano

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

publication date

4 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

901-905

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

3 April 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Genital Ulcerative Pyoderma Gangrenosum in Behçet's Disease: A Case Report and Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Intestinal Behcet's disease with pyoderma gangrenosum: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Effective strategies for the management of pyoderma gangrenosum: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Adalimumab: a treatment option for pyoderma gangrenosum after failure of systemic standard therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Etiology and management of pyoderma gangrenosum: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Prediction of free bowel perforation in patients with intestinal Behçet's disease using clinical and colonoscopic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2016.1174327

10.3109/14397595.2016.1174327

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27142127%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference